Investors

Insider Transactions

Date Name Sorted Descending Title Type Shares Traded Price Range
Nov 30, 2012 roberts william Officer Sell 11,500 177.43 - 186.00
Nov 27, 2012 roberts william Officer Disposition (Non Open Market) 11,500 n/a
Nov 27, 2012 roberts william Officer Acquisition (Non Open Market) 11,500 n/a
Nov 5, 2012 roberts william Officer Acquisition (Non Open Market) 26,000 n/a
Nov 5, 2012 roberts william Officer Disposition (Non Open Market) 26,000 n/a
Sep 4, 2012 roberts william Officer Acquisition (Non Open Market) 19,947 n/a
Aug 24, 2012 roberts william Officer Automatic Sell 3,500 n/a
Aug 23, 2012 roberts william Officer Automatic Sell 15,000 144.00
Jan 11, 2012 roberts william Officer Automatic Sell 22,148 73.99 - 77.05
Jan 10, 2012 roberts william Officer Option Execute 60,000 20.32 - 21.92
Jan 10, 2012 roberts william Officer Automatic Sell 37,852 73.92 - 74.35
Dec 7, 2011 roberts william Officer Disposition (Non Open Market) 3,647 n/a
Dec 7, 2011 roberts william Officer Disposition (Non Open Market) 5,812 n/a
Sep 7, 2011 roberts william Officer Automatic Sell 6,503 67.48 - 70.38
Sep 6, 2011 roberts william Officer Option Execute 30,000 11.64
Sep 6, 2011 roberts william Officer Automatic Sell 23,497 62.76 - 68.41
Jul 14, 2011 roberts william Officer Automatic Sell 110 56.43 - 57.07
Jul 13, 2011 roberts william Officer Automatic Sell 4,322 56.71 - 57.47
Jul 12, 2011 roberts william Officer Automatic Sell 3,939 56.67 - 57.55
Jul 11, 2011 roberts william Officer Automatic Sell 4,129 57.48 - 59.06
Showing 401-420 of 873 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)